Home Your basket
• Solitary fibrous tumor of...
   Price 14.00 €
• Viral assumption and inve...
   Price 10.50 €
• Reports to the General As...
   Price 10.50 €
• Massive bone dystrophic l...
   Price 5.50 €
• High click stimulus repet...
   Price 10.50 €
• New indications for heari...
   Price 8.50 €
• Implementation of the Eur...
   Price 10.50 €
• Mucosal melanomas of the ...
   Price 8.50 €
• Tympanoplasty: Experience...
   Price 12.00 €
• Distortion product otoaco...
   Price 10.50 €
• Stingy speakers....
   Price 5.50 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• Tuberculosis of the laryn...
   Price 5.50 €
• Giant metastasis invading...
   Price 5.50 €
• A protocol for the evalua...
   Price 8.50 €
• Complete branchial cleft ...
   Price 5.50 €
• Are we sectioning the coc...
   Price 10.50 €
• Facial paralysis: Functio...
   Price 10.50 €
• Salvage composite resecti...
   Price 10.50 €
• Audit of headache followi...
   Price 5.50 €
• Hearing loss and vestibul...
   Price 10.50 €
• Arachnoid granulations of...
   Price 10.50 €
• Proposition of adaptation...
   Price 10.50 €
• What is the effect of diz...
   Price 10.50 €
• Partial hearing recovery ...
   Price 5.50 €
• Results of alginate and h...
   Price 10.50 €
• Laryngeal cryptococcosis ...
   Price 8.50 €
• Necrotizing external otit...
   Price 10.50 €
• Ectopic thyroid basi-ling...
   Price 10.50 €
• Cottle's technique septop...
   Price 5.50 €
• The application of tusso...
   Price 10.50 €
• A comparative acoustic st...
   Price 5.50 €
• Zenker’s diverticulum in ...
   Price 8.50 €

Total Order 291.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 3 - 2008 o

CERVICO-FACIAL CARCINOLOGY

Sarcomatoid carcinomas of the upper airways


Authors : Oueslati Z, Ben Miled M, Hammoud M, Touati S, Lachkham A, Gamoudi A, Mokni N, El Benna F, Boussen H, El May A, Ladgham A. (Tunis)

Ref. : Rev Laryngol Otol Rhinol. 2008;129,3:191-195.

Article published in french
Downloadable PDF document french



Summary : Introduction: The sarcomatoid carcinoma of the superior aerodigestive tracts is a rare malignant tumour, which presents diagnostic and therapeutic challenges. Material and method: We report 11 cases of spindle cell carcinomas of the upper airways. Results: Sex-ratio was 10:1 and the mean age was 57.3 years (30 - 75 years). Nine patients were smokers and 4 presented with a history of radiation exposure. Tumoral locations were as follows: larynx: 6, hypopharynx: 1, oropharynx: 1, nasopharynx: 1, oral cavity: 2. Histological diagnosis in 3 cases required the use of immunohistochemical studies. Four patients were first seen at an advanced stage. This left 9 patients and among them 7 received a curative treatment: 5 by surgery alone, 1 by surgery and radiotherapy, 1 by radiotherapy, 1 by chemo-radiotherapy for the nasopharyngeal lesion and 1 by chemotherapy alone. Two patients died from their disease before treatment. With an average delay of 15.4 months, the rates of global survival and disease-free were 5/9 and 4/9 respectively. Conclusion: The sarcomatoid carcinoma of the upper airways is rare, but not unusual. Its diagnosis benefits from progresses in immunohistochemistry, but also from advances in the field of molecular biology. Its treatment and natural evolution remain controversial.

Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE